SIAH3, or Seven In Absentia Homolog 3, is a protein that is encoded by the SIAH3 gene in humans. The SIAH protein family, which includes SIAH1 and SIAH2, is known for its function as E3 ubiquitin-protein ligases, enzymes that tag specific proteins for degradation by the proteasome, a protein complex responsible for degrading unneeded or damaged proteins. This tagging is facilitated by the attachment of ubiquitin molecules to the protein substrates in a process called ubiquitination.
SIAH3 shares sequence homology with other SIAH family members, particularly in the RING domain that is characteristic of E3 ubiquitin ligases. This domain is crucial for the ligase activity, as it is involved in the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to the protein substrate. However, SIAH3 is somewhat unique among its family due to a large insert in its sequence that suggests it might have a different substrate specificity or regulatory mechanism compared to SIAH1 and SIAH2.While the precise biological functions of SIAH3 remain less understood, its structural similarities to other SIAH proteins suggest that it may play a role in the ubiquitin-proteasome system, potentially governing the turnover of proteins that are involved in cell signaling pathways, cell cycle regulation, or apoptosis. Since the ubiquitin-proteasome system is critical for cellular homeostasis, any dysregulation could have profound effects on cell function and could contribute to the pathogenesis of diseases, including cancer and neurodegenerative disorders.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that may indirectly affect SIAH3 activity by altering proteasomal degradation pathways. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Another proteasome inhibitor, lactacystin could indirectly influence SIAH3 by modifying ubiquitin-proteasome system dynamics. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A specific proteasome inhibitor, bortezomib could impact SIAH3 function by affecting proteasomal degradation. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates ubiquitin ligase activity and might influence SIAH3 indirectly. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of NEDD8-activating enzyme, MLN4924 affects ubiquitination processes, potentially impacting SIAH3. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Can modulate multiple signaling pathways and might indirectly affect SIAH3 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences various cellular processes, potentially affecting SIAH3. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
An HSP90 inhibitor, 17-AAG might affect SIAH3 by modulating protein folding and degradation pathways. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Similar to 17-AAG, as an HSP90 inhibitor, geldanamycin could indirectly influence SIAH3 function. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Modulates cellular stress responses, might have an indirect effect on SIAH3. | ||||||